PANAGORA ASSET MANAGEMENT INC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$121,078
-84.5%
29,676
-81.0%
0.00%
-80.0%
Q4 2022$782,728
-58.5%
155,922
+8.2%
0.01%
-61.5%
Q3 2022$1,885,000
+54.0%
144,144
+50.9%
0.01%
+62.5%
Q2 2022$1,224,000
+10.3%
95,505
+31.2%
0.01%
+33.3%
Q1 2022$1,110,000
-6.6%
72,816
+8.6%
0.01%0.0%
Q4 2021$1,188,00067,0660.01%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders